1 ml contains: methionyl-glutamyl-histidyl-phenylalanyl-prolyl-glycyl-proline 1 mg. Auxiliary substances: purified water, methyl para-hydroxybenzoate.
Semax drops nasal 0.1% has the original mechanism of neurospecific action on the central nervous system (CNS). Semax drops nasal 0.1% synthetic analogue of corticotropin, which has nootropic properties and is completely devoid of hormonal activity. The drug affects the processes associated with the formation of memory and learning. Semax drops nasal 0.1% enhances attention in teaching and analyzing information, improves the consolidation of a memorable trace in patients after neurosurgical interventions, cerebral trauma, suffering from cerebrovascular diseases, including dyscirculatory encephalopathy; improves the body's adaptation to hypoxia, cerebral ischemia, anesthesia and other damaging effects. The drug is practically non-toxic with a single and long-term administration. Does not show allergic, embryotoxic, teratogenic and mutagenic properties. Does not have a local irritating effect.
Absorbed from the mucous membrane of the nasal cavity, while absorbed up to 60-70% in terms of the active substance. Semax nasal drops 0.1% is quickly distributed to all organs and tissues, penetrates the blood-brain barrier. When released into the blood, Semax nasal drops 0.1% undergo rapid biotransformation and elimination from the body with urine.
Intellectual-mnestic (memory, attention) disorders, conditions after traumatic brain injury and neurosurgical operations. prevention and treatment of post-anesthetic and asthenoneurotic disorders of various origins. to enhance adaptation in extreme situations. prevention of mental fatigue. Ophthalmology: optic nerve atrophy, inflammatory neuritis, toxic-allergic and vascular etiology, glaucomatous optic neuropathy (glaucoma), diabetic retinopathy. In pediatrics, it is used to treat minimal brain dysfunctions.
Hypersensitivity to the components of the drug. Acute psychotic states, disorders accompanied by anxiety. Pregnancy, breastfeeding. Endocrine diseases.
Due to the fact that the drug is administered intranasally (in the nose), the simultaneous administration of drugs with a vasoconstrictive effect of a local nature is not recommended.
Use during pregnancy and lactation
Use during pregnancy and lactation is contraindicated. No clinical studies have been conducted.
Dosage and administration
Semax is applied intranasally. Memory impairment - 3 drops in each nasal passage 2 times a day for 10 days, 2 courses per year are recommended. Chronic brain ischemia, astheno-neurotic disorders - 3 drops in each nasal passage for 16 days, 2-4 courses per year are recommended. Prevention of stroke and TIA - 3 drops in each nasal passage 2 times a day for 10 days, 2 courses per year are recommended. The recovery period after a stroke and TIA - 4 drops in each nasal passage 6 times a day for 16 days. Prevention (prevention) of recurrent strokes and TIA - 3 drops in each nasal passage 3 times a day for 16 days, 2-3 courses per year are recommended. Traumatic brain injuries and neurosurgical operations - 3 drops in each nasal passage 3 times a day for 16 days, a repeated course is recommended after 6 months. Treatment of post-narcotic disorders of memory and attention - 3 drops in each nasal passage 3 times a day for 6 days. Minimal cerebral dysfunctions in children, including attention deficit hyperactivity disorder (ADHD) - 2 drops in each nasal passage 3 times a day for 20 days, 2-4 courses per year are recommended. Glaucoma, optic nerve atrophy - 2 drops in each nasal passage 3 times a day for 20 days, 2-4 courses per year are recommended. Improving performance, improving memory, reducing stress - 3 drops in each nasal passage 2 times a day for 10 days, it is recommended 1-2 courses per year.
With prolonged use is possible - a slight irritation of the nasal mucosa.
The effects of drug overdose have so far failed to reveal even with a significant increase in a single dose.
Interaction with other drugs
Based on the chemical structure of the drug, the presence of chemically incompatible combinations is not expected: the drug quickly collapses and does not enter the gastrointestinal tract. intraiaseal route of administration, the effect of other drugs on the pharmacokinetic parameters of Semax drops nasal 0.1% is not expected. Considering the way of administration of Semax drops nasal drops of 0.1% (intranasal), it is undesirable to administer agents with local vasoconstrictor action when administered intranasally.
Contraindicated in children under 7 years old, and in ophthalmic and neurosurgical practice, use in children up to 18 years is contraindicated.